1 Followers
39 Following
vikram8588

Research Reports

DataM Intelligence was established on an elemental idea of publishing Advanced Market Research Reports with precise data points & utmost accuracy that will accelerate the decision making in designing disruptive solutions

Macular Edema Market, Size, Share, Outlook and Growth Opportunities 2019-2026

Market Overview

  • Global Macular Edema Market Expected to reach a high CAGR of 10.43% By 2026: DataM Intelligence

 

Download free sample: https://www.datamintelligence.com/download-sample/macular-edema-market

 

Market Dynamic

  • Macular Edema is a condition in which fluid gathers in macular and leads to vision impairment and loss of vision in certain conditions.
  • Advancements in technologies in the development of new drug delivery systems, the introduction of new drug combinations, rise in macular edema patients are the major factors driving the growth of the macular edema market across the globe.
  • Increasing the diabetic population which in turn could result in macular edema is also one of the factors driving the growth of the market. Stringent regulations across various regions, availability of alternative therapies, and the high cost of the drugs/medication are the major factor restraining the growth of the market.

 

Segmentation Analysis

  • The macular edema market is segmented by clinical trial analysis, by molecular type, and by geography.
  • By geography, North America has the largest market share in 2017 accounting for more than half of the market value and this is followed by Europe. Emerging markets are witnessing a faster growth in the market with the Asia-Pacific region growing at a faster growth rate.

 

Competitive Analysis

  • The global macular edema market is a consolidated market with the top 4 companies accounting for the largest market share. Some of the recent industry developments include
  • FDA approves Roche’s Lucentis for treatment of diabetic retinopathy in people with diabetic macular edema
  • Eylea injection recommended for approval for the treatment of visual impairment due to diabetic macular edema in the European Union

Market Key Players

  • Novartis
  • Roche
  • Pfizer
  • Regeneron Pharmaceuticals

 

View full report: https://www.datamintelligence.com/research-report/macular-edema-market

 

Enquiry before buying: https://www.datamintelligence.com/enquiry/macular-edema-market

 

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.

 

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: info@datamintelligence.com

Tel: +1 877 441 4866

Website: www.datamintelligence.com

Source: http://www.datamintelligence.com/research-report/macular-edema-market